Second primary breast cancer during PARP inhibitor treatment of somatic BRCA mutant ovarian cancer – a case report

Dragoş Mircea Median, Simona Coniac, Andreea-Iuliana Miron

Ovarian cancer is the fifth cause of death by cancer in the female population from Romania(1). Mutations in the BRCA1 (breast cancer gene 1) and BRCA2 (breast cancer gene 2) lead to an increased risk ...